PTC Therapeutics
PTCT
PTCT
182 hedge funds and large institutions have $2.71B invested in PTC Therapeutics in 2022 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 65 increasing their positions, 58 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
2.23% less ownership
Funds ownership: 106.61% → 104.39% (-2.2%)
10% less capital invested
Capital invested by funds: $3B → $2.71B (-$297M)
Holders
182
Holding in Top 10
4
Calls
$1.99M
Puts
$1.28M
Top Buyers
| 1 | +$79.1M | |
| 2 | +$37.3M | |
| 3 | +$14.3M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$5.91M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$5.53M |
Top Sellers
| 1 | -$87.6M | |
| 2 | -$45.5M | |
| 3 | -$14.5M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$14.1M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$12.2M |